Mirae Asset Global Investments
WST icon

Mirae Asset Global Investments’s West Pharmaceutical WST Stock Holding History

Mirae Asset Global Investments’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.86M Buy
21,896
+983
+5% +$301K 0.01% 499
2026
Q1 		$5.24M Buy
20,913
+3,475
+20% +$865K 0.02% 538
2025
Q4 		$4.8M Buy
17,438
+1,999
+13% +$547K 0.01% 562
2025
Q3 		$4.05M Buy
15,439
+665
+5% +$162K 0.01% 569
2025
Q2 		$3.23M Buy
14,774
+1,990
+16% +$425K 0.01% 576
2025
Q1 		$2.84M Buy
12,784
+1,893
+17% +$522K 0.01% 578
2024
Q4 		$3.62M Buy
10,891
+2,338
+27% +$736K 0.01% 516
2024
Q3 		$2.66M Buy
8,553
+2,476
+41% +$758K 0.01% 537
2024
Q2 		$2M Sell
6,077
-22,323
-79% -$7.89M 0.01% 576
2024
Q1 		$9.98M Buy
28,400
+5,690
+25% +$2.1M 0.02% 639
2023
Q4 		$8M Sell
22,710
-544
-2% -$193K 0.02% 730
2023
Q3 		$8.73M Sell
23,254
-777
-3% -$300K 0.02% 665
2023
Q2 		$9.19M Sell
24,031
-4,890
-17% -$1.75M 0.02% 687
2023
Q1 		$10M Buy
28,921
+295
+1% +$86.2K 0.02% 644
2022
Q4 		$6.74M Buy
28,626
+13,956
+95% +$3.31M 0.02% 733
2022
Q3 		$3.61M Buy
14,670
+1,351
+10% +$412K 0.01% 915
2022
Q2 		$4.03M Buy
13,319
+2,578
+24% +$839K 0.01% 907
2022
Q1 		$4.41M Buy
+10,741
New +$4.2M 0.01% 919
2021
Q4 		– Sell
-6,470
Closed -$2.75M – 1774
2021
Q3 		$2.75M Buy
6,470
+1,427
+28% +$602K 0.01% 1027
2021
Q2 		$1.81M Buy
+5,043
New +$1.67M 0.01% 1092
2021
Q1 		– Sell
-3,750
Closed -$1.06M – 1640
2020
Q4 		$1.06M Buy
3,750
+719
+24% +$202K ﹤0.01% 1127
2020
Q3 		$833K Buy
3,031
+845
+39% +$224K ﹤0.01% 1031
2020
Q2 		$497K Buy
+2,186
New +$430K ﹤0.01% 1145

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Mirae Asset Global Investments's WST Position: Q2 2026 in Review

Mirae Asset Global Investments increased its West Pharmaceutical (WST) stake by 4.7% in Q2 2026, buying an estimated $301K and bringing the position to 21,896 shares worth $7.86M. The position accounts for 0.01% of the portfolio, ranked #499.

Mirae Asset Global Investments first reported a position in WST in Q2 2020 and has held it in 23 quarters since. The position peaked at $10M in Q1 2023. 834 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Mirae Asset Global Investments held 21,896 shares of West Pharmaceutical worth $7.86M as of Q2 2026.
  • Mirae Asset Global Investments bought 983 West Pharmaceutical shares in Q2 2026, an estimated $301K.
  • West Pharmaceutical made up 0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #499 holding.
  • Mirae Asset Global Investments first reported a position in West Pharmaceutical in Q2 2020 and has held it in 23 quarters since.
  • Mirae Asset Global Investments's West Pharmaceutical position peaked at $10M in Q1 2023.
  • 834 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.